Riskpilot← Back to searchSign inGet full accessCytiva Testa Center AB
ABActiveOrg 5590864327Björkgatan 30Research and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2024
SEK 15,1M
0% vs 2023
EBITDA margin
16.6%
-4% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
SEK -1K
-101% vs 2023
| Revenue | SEK 15,1M | +0% |
| EBITDA | SEK 2,5M | -4% |
| Net profit | SEK -1K | -101% |
| Total assets | SEK 58,9M | -4% |
| Equity | SEK 55,8M | +0% |
| Employees | 0 | — |
Legal name
Cytiva Testa Center AB
Org number
5590864327
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 november 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget är ett icke-vinstdrivande företag vars syfte är driva en testbädd i Uppsala bestående av infrastruktur och relevanta tjänster för stöd till utförande av vetenskapliga tester med avseende på Biologi och Teknik inom området utveckling av verktyg och teknologier för produktion av Biomolekyler inom life sciences, samt bedriva därmed förenlig verksamhet. Bolaget har till föremål för sin verksamhet att tillhandahålla en anläggning till vilken tillträde kan beviljas flera användare parallellt på ett transparent och icke-diskriminerande sätt. Målgruppen är Universitet, forskargrupper samt små och stora teknik- och bioteknikbolag som kan dra nytta av bolagets infrastruktur och kompetens inom forskning och utveckling.
Address
Björkgatan 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 175 | 13 052 | 16 031 | 15 156 | 15 115 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 167 | 1 953 | 6 333 | 2 623 | 2 514 |
| Depreciation & amort. | −2 303 | −2 625 | −2 871 | −2 996 | −3 030 |
| EBIT | −1 136 | −672 | 3 462 | −373 | −516 |
| Net financials | — | — | — | 480 | 515 |
| Profit before tax | −1 136 | −672 | 3 462 | 107 | −1 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 136 | −672 | 3 462 | 107 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 64 768 | 60 780 | 63 252 | 61 447 | 58 909 |
| Equity | 52 919 | 52 246 | 55 709 | 55 816 | 55 814 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 849 | 8 533 | 7 543 | 5 632 | 3 095 |
| Total debt | 11 849 | 8 533 | 7 543 | 5 632 | 3 095 |
EBITDA margin
16.6%
This company
15.8%
Market median
+5% vs market
20202024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20202024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JM Chief Auditor | Chief Auditor | 2022 |
JJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
IC Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
BA Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PALL NETHERLANDS B.V
Cytiva Testa Center AB Board members of Cytiva Testa Center AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonatan Mattias Hansson | Chief Auditor | 0 companies |
| Ingrid Charlotta Ljungqvist | Chief Executive Officer | 0 companies |
| Bjarne Alfred Andreassen | Chief Auditor | 0 companies |
| Jan Jesper Hedberg | Chief Executive Officer | 0 companies |
| Scott James Ripley | Chairman | 0 companies |
| Ann-Christine M Hult Löfgren | Board of Directors | 0 companies |